259 related articles for article (PubMed ID: 24942944)
1. Treatment of follicular lymphoma.
Izutsu K
J Clin Exp Hematop; 2014; 54(1):31-7. PubMed ID: 24942944
[TBL] [Abstract][Full Text] [Related]
2. Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphoma.
Trotman J; Cheah CY; Marlton P; Opat S
Intern Med J; 2019 Apr; 49(4):422-433. PubMed ID: 30230156
[TBL] [Abstract][Full Text] [Related]
3. Advancements in the Management of Follicular Lymphoma: A Comprehensive Review.
Merryman R; Mehtap Ö; LaCasce A
Turk J Haematol; 2024 May; 41(2):69-82. PubMed ID: 38660754
[TBL] [Abstract][Full Text] [Related]
4. Individualized management of follicular lymphoma.
Bai B; Huang HQ
Chin Clin Oncol; 2015 Mar; 4(1):7. PubMed ID: 25841714
[TBL] [Abstract][Full Text] [Related]
5. [Low grade lymphoma: research progress and questions about treatment].
Ishizawa K
Rinsho Ketsueki; 2015 Oct; 56(10):2039-46. PubMed ID: 26458443
[TBL] [Abstract][Full Text] [Related]
6. Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study.
Mondello P; Steiner N; Willenbacher W; Cerchione C; Nappi D; Mauro E; Ferrero S; Cuzzocrea S; Mian M
Oncologist; 2018 Apr; 23(4):454-460. PubMed ID: 29317554
[TBL] [Abstract][Full Text] [Related]
7. Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era.
Nastoupil LJ; Sinha R; Byrtek M; Ziemiecki R; Zhou X; Taylor M; Friedberg JW; Link BK; Cerhan JR; Dawson K; Flowers CR
Br J Haematol; 2016 Mar; 172(5):724-34. PubMed ID: 26729445
[TBL] [Abstract][Full Text] [Related]
8. [Follicular lymphoma].
Tomita N
Nihon Rinsho; 2014 Mar; 72(3):488-92. PubMed ID: 24724409
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
[TBL] [Abstract][Full Text] [Related]
10. Is There a Best Initial Treatment for a New Patient With Low Grade Follicular Lymphoma.
Jacobson CA; Freedman AS
Curr Hematol Malig Rep; 2016 Jun; 11(3):218-23. PubMed ID: 26995595
[TBL] [Abstract][Full Text] [Related]
11. [Management strategy for follicular lymphoma].
Fukuhara N
Rinsho Ketsueki; 2017; 58(10):2020-2025. PubMed ID: 28978844
[TBL] [Abstract][Full Text] [Related]
12. Transformed follicular lymphoma (tFL): consolidation therapy may improve survival.
Elhassadi E; Flavin R; Browne P; Conneally E; Hayden P; Quinn F; Higgins E; Vandenberghe E
Ir J Med Sci; 2017 Aug; 186(3):589-595. PubMed ID: 28321641
[TBL] [Abstract][Full Text] [Related]
13. [The current therapeutic landscape for follicular lymphoma].
Kobayashi T
Rinsho Ketsueki; 2021; 62(8):1070-1076. PubMed ID: 34497193
[TBL] [Abstract][Full Text] [Related]
14. Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study.
Martin P; Byrtek M; Dawson K; Ziemiecki R; Friedberg JW; Cerhan JR; Flowers CR; Link BK
Cancer; 2013 Dec; 119(23):4129-36. PubMed ID: 24006156
[TBL] [Abstract][Full Text] [Related]
15. [Follicular lymphoma: recent advances].
Ando K
Rinsho Ketsueki; 2018; 59(10):2104-2108. PubMed ID: 30305515
[TBL] [Abstract][Full Text] [Related]
16. Follicular lymphoma.
Ghielmini M
Ann Oncol; 2010 Oct; 21 Suppl 7():vii151-3. PubMed ID: 20943608
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of short-course CHOP-R followed by 90Y-ibritumomab tiuxetan and extended rituximab in previously untreated follicular lymphoma.
Jacobs SA; Swerdlow SH; Kant J; Foon KA; Jankowitz R; Land SR; DeMonaco N; Joyce J; Osborn JL; Evans TL; Schaefer PM; Luong TM
Clin Cancer Res; 2008 Nov; 14(21):7088-94. PubMed ID: 18981007
[TBL] [Abstract][Full Text] [Related]
18. Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experience.
Bourcier J; Gastinne T; Leux C; Moreau A; Bossard C; Mahé B; Blin N; Dubruille V; Touzeau C; Voldoire M; Guillaume T; Peterlin P; Gallas P; Garnier A; Maisonneuve H; Moreau P; Juge-Morineau N; Jardel H; Chevallier P; Moreau P; Le Gouill S
Ann Hematol; 2016 Aug; 95(8):1287-93. PubMed ID: 27297970
[TBL] [Abstract][Full Text] [Related]
19. Current approaches and future perspectives for advanced-stage follicular lymphoma with a low tumor burden.
Fukuhara N; Ishizawa K
Jpn J Clin Oncol; 2019 Apr; 49(4):306-310. PubMed ID: 30715424
[TBL] [Abstract][Full Text] [Related]
20. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]